Overview
Share price and charges
Series
FNAV
2.86% change
-4.67%Management fee
0.72%Operating expenses
0.07%Gross expense ratio
0.79%Net expense ratio
0.79%Fund facts
Fund launch date
31 May 2001
Fund size
$717.0m
Benchmark
MSCI Emerging Markets Index
Current number of holdings
72
Active share
68%**
Annual turnover
18%
Style
Growth
Guideline number of holdings
60-100
** Relative to MSCI Emerging Markets Index.
Source: Baillie Gifford & Co and relevant underlying index provider(s).
Portfolio characteristics
The fund's characteristics compared to the index.
As at 31 March 2025
| Fund | MSCI Emerging Markets Index | |
|---|---|---|
| Market cap (weighted average) | $280.64bn | $228.50bn |
| Price / Book | 2.35 | 1.96 |
| Price / Earnings (12 months forward) | 12.40 | 11.93 |
| Earnings growth (5 year historic) | 9.84% | 9.59% |
| Return on equity (12 months forward) | 18.84% | 15.78% |
| Standard deviation (trailing 3 years) | 17.03% | 14.26% |
| Beta | 1.18 | N/A |
Source: Revolution, MSCI. Canadian dollars.
Index disclaimer
Source: MSCI. The MSCI information may only be used for your internal use, may not be reproduced or redisseminated in any form and may not be used as a basis for or a component of any financial instruments or products or indices. None of the MSCI information is intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such. Historical data and analysis should not be taken as an indication or guarantee of any future performance analysis, forecast or prediction. The MSCI information is provided on an ‘as is’ basis and the user of this information assumes the entire risk of any use made of this information. MSCI, each of its affiliates and each other person involved in or related to compiling, computing or creating any MSCI information (collectively, the ‘MSCI Parties’) expressly disclaims all warranties (including, without limitation, any warranties or originality, accuracy, completeness, timeliness, non-infringement, merchantability and fitness for a particular purpose) with respect to this information. Without limiting any of the foregoing, in no event shall any MSCI Party have any liability for any direct, indirect, special, incidental, punitive, consequential (including, without limitation, lost profits) or any other damages (www.msci.com).
Important information
The information provided does not constitute an offer of or solicitation for purchase or sale of securities or provision of any investment services. Baillie Gifford does not currently have any funds that offer securities under a simplified prospectus for general offer or sale within Canada. No securities regulatory authority in Canada has reviewed or in any way passed upon this website or the merits of any investment available, and any representation to the contrary is an offence.
Persons resident or domiciled in Canada should consult with their professional advisers as to whether they require any governmental or other consents in order to enable them to trade.
You can read details of our Legal and Important Information here.
Trade Matching Statement
This Trade-Matching Statement is being provided in accordance with National Instrument 24-101 -"Institutional Trade Matching and Settlement" and Companion Policy 24-101 CP (the "National
Instrument"). It applies to all trades that are subject to the National Instrument. View the whole statement.
